Brian Lian
Known title: President & CEOCIK: 0001614578
Associated companies
Transaction History
| VKTX | ▼ Sell | Open Market | 148,517 | $4.9M | 7/29/2026 | View on chart |
| VKTX | ▲ Buy | Grant | 221,667 | $0 | 7/28/2026 | View on chart |
| VKTX | ▼ Sell | Open Market | 132,454 | $4.3M | 1/5/2026 | View on chart |
| VKTX | ▼ Sell | Open Market | 53,279 | $1.8M | 1/5/2026 | View on chart |
| VKTX | ▼ Sell | Open Market | 41,276 | $1.4M | 1/5/2026 | View on chart |
| VKTX | ▼ Sell | Open Market | 6,400 | $224K | 1/5/2026 | View on chart |
| VKTX | ▲ Buy | Grant | 224,080 | $0 | 1/2/2026 | View on chart |
| VKTX | ▲ Buy | Grant | 78,400 | $0 | 1/2/2026 | View on chart |
| VKTX | ▼ Sell | Open Market | 38,989 | $1.4M | 10/28/2025 | View on chart |
| VKTX | ▲ Buy | Grant | 70,084 | $0 | 10/27/2025 | View on chart |
| VKTX | ▼ Sell | Open Market | 26,889 | $748K | 7/3/2025 | View on chart |
| VKTX | ▲ Buy | Grant | 48,333 | $0 | 7/2/2025 | View on chart |
| VKTX | ▼ Sell | Open Market | 175,490 | $7.5M | 1/6/2025 | View on chart |
| VKTX | ▼ Sell | Open Market | 19,000 | $823K | 1/6/2025 | View on chart |
| VKTX | ▲ Buy | Grant | 92,800 | $0 | 1/3/2025 | View on chart |
| VKTX | ▲ Buy | Grant | 163,333 | $0 | 1/3/2025 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 166,130 | $1.3M | 9/20/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 96,056 | $6.8M | 9/20/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 119,874 | $8.5M | 9/20/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 200 | $14K | 9/20/2024 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 1,000 | $8K | 8/21/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 1,000 | $70K | 8/21/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 70,132 | $4.6M | 8/19/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 11,296 | $758K | 8/19/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 31,442 | $2.1M | 8/19/2024 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 112,870 | $877K | 8/19/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 19,501 | $1.1M | 7/30/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 30,417 | $1.8M | 7/30/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 65,941 | $3.8M | 7/30/2024 | View on chart |
| VKTX | ▲ Buy | Grant | 163,333 | $0 | 7/29/2024 | View on chart |
| VKTX | ▲ Buy | Grant | 41,000 | $0 | 7/29/2024 | View on chart |
| VKTX | ▲ Buy | Grant | 221,667 | $0 | 3/27/2024 | View on chart |
| VKTX | ▼ Sell | Tax Withholding | 153,948 | $12.8M | 3/27/2024 | View on chart |
| VKTX | ▼ Sell | Tax Withholding | 162,815 | $13.9M | 3/1/2024 | View on chart |
| VKTX | ▲ Buy | Grant | 221,667 | $0 | 3/1/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 45,000 | $1.3M | 2/9/2024 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 49,079 | $60K | 2/8/2024 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 140,000 | $651K | 2/8/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 40,000 | $1.1M | 2/8/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 80,000 | $2.2M | 2/8/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 40,000 | $1.2M | 2/8/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 60,000 | $1.6M | 2/8/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 49,079 | $1.3M | 2/8/2024 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 85,000 | $105K | 1/31/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 45,000 | $1.1M | 1/31/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 40,000 | $978K | 1/31/2024 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 35,000 | $43K | 1/30/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 35,000 | $838K | 1/30/2024 | View on chart |
| VKTX | ▼ Sell | Tax Withholding | 39,552 | $735K | 1/4/2024 | View on chart |
| VKTX | ▼ Sell | Tax Withholding | 108,525 | $1.9M | 1/3/2024 | View on chart |
| VKTX | ▼ Sell | Tax Withholding | 106,115 | $1.8M | 1/3/2024 | View on chart |
| VKTX | ▲ Buy | Grant | 160,000 | $0 | 1/3/2024 | View on chart |
| VKTX | ▲ Buy | Grant | 150,000 | $0 | 1/3/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 45,000 | $1.0M | 5/1/2023 | View on chart |
| VKTX | ▼ Sell | Open Market | 35,000 | $751K | 4/19/2023 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 125,000 | $269K | 4/17/2023 | View on chart |
| VKTX | ▼ Sell | Open Market | 155,000 | $3.2M | 4/17/2023 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 54,336 | $102K | 4/13/2023 | View on chart |
| VKTX | ▼ Sell | Open Market | 79,336 | $1.5M | 4/13/2023 | View on chart |
| VKTX | ▼ Sell | Tax Withholding | 200,000 | $3.5M | 4/3/2023 | View on chart |
| VKTX | ▼ Sell | Open Market | 22,000 | $393K | 4/3/2023 | View on chart |
| VKTX | ▲ Buy | Grant | 300,000 | $0 | 4/3/2023 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 67,970 | $645K | 3/31/2023 | View on chart |
| VKTX | ▼ Sell | Open Market | 67,970 | $1.2M | 3/31/2023 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 115,852 | $142K | 3/30/2023 | View on chart |
| VKTX | ▼ Sell | Open Market | 65,382 | $1.1M | 3/30/2023 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 19,530 | $185K | 3/30/2023 | View on chart |
| VKTX | ▼ Sell | Open Market | 88,000 | $1.5M | 3/30/2023 | View on chart |
| VKTX | ▼ Sell | Tax Withholding | 28,619 | $241K | 1/4/2023 | View on chart |
| VKTX | ▼ Sell | Tax Withholding | 68,252 | $582K | 1/3/2023 | View on chart |
| VKTX | ▲ Buy | Grant | 266,667 | $0 | 1/3/2023 | View on chart |
| VKTX | ▼ Sell | Tax Withholding | 66,127 | $622K | 12/30/2022 | View on chart |
| VKTX | ▲ Buy | Grant | 121,667 | $0 | 12/30/2022 | View on chart |
| VKTX | ▼ Sell | Tax Withholding | 26,432 | $122K | 1/4/2022 | View on chart |
| VKTX | ▼ Sell | Tax Withholding | 36,319 | $177K | 1/3/2022 | View on chart |
| VKTX | ▲ Buy | Grant | 173,333 | $0 | 1/3/2022 | View on chart |
| VKTX | ▼ Sell | Tax Withholding | 27,750 | $180K | 9/28/2021 | View on chart |
| VKTX | ▲ Buy | Grant | 55,500 | $0 | 9/28/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Viking Therapeutics Launches New Oral Obesity Study
Viking Therapeutics announced a new oral maintenance study for its obesity program, a key step in its drug development pipeline. This news comes as the stock has fallen over 30% in the last three months, trading near its 52-week low. While an analyst recently maintained a buy rating with a lowered price target, the broader market view remains mixed given the recent price decline.
Viking Therapeutics Launches New Oral Obesity Study. Viking Therapeutics announced a new oral maintenance study for its obesity program, a key step in its drug development pipeline. This news comes as the stock has fallen over 30% in the last three months, trading near its 52-week low. While an analyst recently maintained a buy rating with a lowered price target, the broader market view remains mixed given the recent price decline.